Datopotamab Deruxtecan
Drug timelines are a Plus or Pro feature.
7 regulatory and trial events tracked for Datopotamab Deruxtecan, covering 2025-05-20 to 2026-03-25. Get the full timeline:
Most recent: Clinical Trial Update: Datopotamab Deruxtecan (Dato-DXd) and Pembrolizumab With or Without Platinum Chemotherapy in 1L Non-Small Cell Lung Cancer (TROPION-Lung07) [Phase 3]